Oppenheimer gave HCA stock an "outperform" rating on Thursday, according to Sleek Monkey.
Here are eight notes:
1. HCA stock has a $105.00 target price, an increase from their previous target price of $102.00.
2. Oppenheimer's target price for HCA stock indicates a potential upside of 12.01 percent from HCA's current price.
3. CMO Jonathan B. Perlin sold 32,010 shares of HCA stock in a transaction occurring Thursday, June 25.
4. The shares sold at an average price of $87.31, for a transaction totaling $2,794,793.
5. CEO R. Milton Johnson additionally sold 140,642 of HCA stock for a transaction totaling $11,798,457. Each share sold for an average price of $83.89.
6. HCA has a one year low of $59.39 and a one year high of $95.49.
7. The stock's 50-day moving average is $86.71 and its 200-day moving average is $77.31.
8. HCA has a market cap of $38.84 billion and a P/E rating of 19.69.
More on surgery centers:
Barnabas Health & Robert Wood Johnson Health System sign partnership agreement, to include ambulatory centers: 4 key notes
Physicians file CON for new surgery center in Vermont: 4 things to know
Tenet stock trading 6.5% below 52-week average: 5 key notes